CSRxP Statement on the Launch of TrumpRx Campaign Appreciates Administration’s Commitment to Lowering Drug Prices, Encourages Administration and Congress to Deliver Lasting Relief for American People by Holding Big Pharma Accountable Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Friday on the launch of TrumpRx. “CSRxP appreciates the Administration’s commitment to lowering drug prices for the American people and looks forward to reviewing the full details of TrumpRx,” said CSRxP executive director Lauren Aronson. “To deliver lasting relief from Big Pharma’s price-gouging and foster greater affordability for the American people with sustainable change, Congress and the Administration must advance market-based solutions to hold Big Pharma accountable for their anti-competitive tactics and egregious pricing practices that are the root cause of high prescription drug prices in America.” Read more on bipartisan, market-based solutions to lower drug prices by holding Big Pharma accountable HERE. ### |
